Study Examines Axi-Cel Use for Follicular Lymphoma Management
Researchers compared chimeric antigen receptor T-cell therapies axicabtagene ciloleucel (axi-cel) and tisagenlecleucel.
Related Keywords
, Cancer Management , Axicabtagene Ciloleucel , Axi Cel , Tisagenlecleucel , Follicular Lymphoma , Cd3zeta , Zuma 5 , Car T ,
comparemela.com © 2020. All Rights Reserved.